Skip to content

SRZNW

Surrozen, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.00
−60.53%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue11.5M3.5M10.7M12.5M
Cost of Revenue65.0K537.0K27.2M3.3M
Gross Profit11.4M2.9M10.7M(27.2M)9.2M
Operating Expenses
R&D Expense34.6M29.4M21.1M27.2M37.0M
SG&A Expense21.3M16.2M15.1M15.8M19.8M
General & Admin Expense21.3M16.2M15.1M15.8M19.8M
Selling & Marketing Expense
Other Expenses(537.0K)(24.5M)(3.3M)
Total Operating Expenses55.8M45.0M36.2M18.6M53.6M
Cost and Expenses55.9M45.6M36.2M45.8M56.8M
Operating Income (EBIT)(44.4M)(42.1M)(25.5M)(45.8M)(44.3M)
Non-Operating
Interest Income3.5M3.0M1.7M2.3M781.0K
Interest Expense
Net Interest Income3.5M3.0M1.7M2.3M781.0K
Other Non-Op Income/Expense(287.8M)(199.9M)(38.0M)2.7M8.3M
Non-Operating Income (excl Interest)287.8M199.9M38.0M(2.7M)(8.3M)
EBT (Pre-Tax Income)(332.1M)(242.0M)(63.6M)(43.0M)(36.0M)
Income Tax Expense
Bottom Line
Net Income(332.1M)(242.0M)(63.6M)(43.0M)(36.0M)
Earnings from Cont. Ops(332.1M)(242.0M)(63.6M)(43.0M)(36.0M)
Earnings from Discont. Ops
Bottom Line Net Income(391.7M)(242.0M)(63.6M)(43.0M)(36.0M)
Per Share
Basic EPS($41.13)($32.37)($21.67)($21.33)($15.55)
Diluted EPS($44.29)($32.37)($21.67)($21.33)($15.55)
Revenue Per Share$0.99$0.46$3.63$0.00$5.40
Shares
Basic Shares Outstanding11.7M7.5M2.9M2.0M2.3M
Diluted Shares Outstanding23.1M7.5M2.9M2.0M2.3M
Profitability Metrics
EBITDA(331.9M)(241.5M)(62.1M)(41.1M)(34.0M)
D&A222.0K537.0K1.4M1.9M2.0M
EBIT(332.1M)(242.0M)(63.6M)(43.0M)(36.0M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026